ZhuHai Cardionovum Medical Device Co., Ltd.
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
A Study of Hemodialysis Arteriovenous Fistulae Stenosis Treated With APERTO
Role: lead
Compare the Efficacy and Safety of RESTORE DEB and SeQuent® Please in Chinese Patient With Coronary In-stent Restenosis
Role: lead
Assess the Efficacy and Safety of RESTORE Paclitaxel Eluting Balloon Versus RESOLUTE Zotarolimus Eluting Stent for the Treatment of Small Coronary Vessel Disease
Role: lead
A Study of The Femoral Popliteal Artery Treated With LEGFLOW OTW
Role: lead
A Study of Below The Knee Arteries' Stenosis or Occlusion Treated With LEGFLOW OTW
Role: lead
All 5 trials loaded